Literature DB >> 1376019

Subretinal fibrosis after laser photocoagulation for diabetic macular edema.

D R Guyer1, D J D'Amico, C W Smith.   

Abstract

Seven eyes had subretinal fibrosis after grid laser photocoagulation for diabetic macular edema. The fibrosis caused persistent loss in visual acuity, and in six of the seven eyes, was not associated with detectable laser-induced Bruch's membrane rupture or subretinal hemorrhage. Choroidal neovascularization was detected in only one patient, who was notably younger (27 years) than the median age of 70 years in this series. The median preoperative visual acuity was 20/80 (range, 20/40 to 20/400); the median postoperative visual acuity was 20/400 (range, 20/80 to counting fingers). The subretinal fibrosis was detected at a median of three months (range, 14 days to 4 1/2 months) after laser therapy. In one of five bilaterally treated patients (20%), subretinal fibrosis developed in both eyes. Subretinal fibrosis may be caused by undetected choroidal neovascularization or by excessive proliferation after stimulation of an aged retinal pigment epithelium. Subretinal fibrosis may be a potential cause of loss in visual acuity after laser treatment for diabetic macular edema.

Entities:  

Mesh:

Year:  1992        PMID: 1376019     DOI: 10.1016/s0002-9394(14)74789-0

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  41 in total

1.  Comparative efficacy of pure yellow (577-nm) and 810-nm subthreshold micropulse laser photocoagulation combined with yellow (561-577-nm) direct photocoagulation for diabetic macular edema.

Authors:  Keiji Inagaki; Kishiko Ohkoshi; Sachiko Ohde; Gautam A Deshpande; Nobuyuki Ebihara; Akira Murakami
Journal:  Jpn J Ophthalmol       Date:  2014-11-14       Impact factor: 2.447

2.  Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema.

Authors:  J K Luttrull; D C Musch; M A Mainster
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

3.  "Light" versus "classic" laser treatment for clinically significant diabetic macular oedema.

Authors:  F Bandello; A Polito; M Del Borrello; N Zemella; M Isola
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

4.  Arteriovenous crossing sheathotomy versus intravitreal triamcinolone acetonide injection for treatment of macular edema associated with branch retinal vein occlusion.

Authors:  Eun Jee Chung; Hyo Lee; Hyoung Jun Koh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-04-19       Impact factor: 3.117

5.  Restoration of retinal structure and function after selective photocoagulation.

Authors:  Alexander Sher; Bryan W Jones; Philip Huie; Yannis M Paulus; Daniel Lavinsky; Loh-Shan S Leung; Hiroyuki Nomoto; Corinne Beier; Robert E Marc; Daniel Palanker
Journal:  J Neurosci       Date:  2013-04-17       Impact factor: 6.167

6.  Efficacy of Pattern Scan Laser photocoagulation for superficial conjunctival nevi ablation.

Authors:  Young Min Park; Ji-Eun Lee; Jong Soo Lee
Journal:  Lasers Med Sci       Date:  2016-02-25       Impact factor: 3.161

7.  Vitrectomy for cystoid macular oedema with attached posterior hyaloid membrane in patients with diabetes.

Authors:  T Ikeda; K Sato; T Katano; Y Hayashi
Journal:  Br J Ophthalmol       Date:  1999-01       Impact factor: 4.638

8.  Indirect scatter laser photocoagulation to subfoveal choroidal neovascularization in age-related macular degeneration.

Authors:  J Arnold; M Algan; G Soubrane; G Coscas; E Barreau
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-04       Impact factor: 3.117

9.  Subthreshold micropulse diode laser treatment in diabetic macular oedema.

Authors:  M L Laursen; F Moeller; B Sander; A K Sjoelie
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

10.  [Intraocular triamcinolone for diffuse diabetic macular edema].

Authors:  R F Degenring; I Kreissig; J B Jonas
Journal:  Ophthalmologe       Date:  2004-03       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.